BRCA1 and breast carcinoma: Two different potential roles have been described for MSCs in the development of triple-negative breast cancer (TNBC) with BRCA1 gene mutation (aka IRIS, for In-frame Reading of BRCA1 Intron 11 Splice variant), which is the most aggressive breast cancer subtype.